Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × orteronel × Clear all

NCT01816048 2019-12-09

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Phase 2 Terminated

8 enrolled 15 charts

Prostatic Neoplasms

NCT01866423 2017-08-31

Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Terminated

4 enrolled 6 charts

Prostatic Neoplasms

NCT03211052 2017-07-07

NEPTUNE

Phase 2 Terminated

Prostatic Neoplasms

NCT01658527 2016-06-10

TAK-700 in Castration Resistant Prostate Cancer

Phase 2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms

NCT01549951 2016-06-01

Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

50 enrolled 22 charts

Prostatic Neoplasms

NCT01046916 2016-04-04

Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen

Phase 2 Completed

Prostatic Neoplasms